Silencing P2X7 receptor downregulates the expression of TCP-1 involved in lymphoma lymphatic metastasis

Xudong Jiang1, Wenjuan Mao1, Ziyi Yang1

  • 1Department of Clinical Biochemistry, College of Laboratory Diagnostic Medicine, Dalian Medical University, Dalian 116044, China.

Oncotarget
|November 12, 2015
PubMed

Insights

The P2X7 receptor (P2X7R) may influence lymphoid neoplasm metastasis. Researchers found that TCP-1 protein levels decrease when P2X7R is silenced, suggesting TCP-1 is a key downstream molecule in this process.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Proteomics

Background:

  • The P2X7 receptor (P2X7R), an ATP-gated cation channel, is involved in cell proliferation and apoptosis.
  • Previous research suggests P2X7R plays a role in the dissemination of P388D1 lymphoid neoplasm cells to peripheral lymph nodes.

Purpose of the Study:

  • To investigate the underlying mechanism of P2X7R's role in lymphoid neoplasm metastasis.
  • To identify downstream molecular targets of P2X7R involved in cancer cell dissemination.

Main Methods:

  • Proteomic analysis using 2D electrophoresis (2DE) and MALDI-TOF mass spectrometry.
  • Analysis of lymph nodes from mice with P388D1 lymphoid neoplasm cells (P2X7R-silenced vs. non-silenced).
  • In vivo and in vitro experiments to validate findings in patient tissues.

Main Results:

  • Proteomics identified 64 differentially expressed proteins between P2X7R-silenced and control groups.
  • TCP-1 (T-complex polypeptide 1) was significantly decreased in P2X7R-silenced cells.
  • A positive correlation between P2X7R and TCP-1 expression was confirmed in mouse models and human lymphoma/lymphadenopathy tissues.

Conclusions:

  • TCP-1 is a potential downstream molecular target of P2X7R.
  • TCP-1 may play a novel role in the metastasis of lymphoid neoplasms.
  • P2X7R-TCP-1 pathway warrants further investigation for therapeutic strategies in lymphoid cancers.